BLAINE JENSEN: Open Payments
NPI 1346390242 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 31 payments from 9 companies in 2025. Trend: 2023 $1,030 · 2024 $1,229 · 2025 $832
Food & beverage: $832
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $399 |
| LEO Pharma Inc. | 5 | $147 |
| ABBVIE INC. | 3 | $73 |
| PFIZER INC. | 3 | $50 |
| Janssen Biotech, Inc. | 2 | $49 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
| Incyte Corporation | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $9 |
Products named: DUPIXENT, ANZUPGO, SKYRIZI, ADBRY, CIBINQO, TREMFYA, Zoryve, OPZELURA.
Industry payments across AZ — which companies pay providers there.
